GlassScriptPhysician profile
Babak Hakimisefat
NPI 1114189354
$1,733.01
in general payments reported to CMS, 2019-2025
23 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $275 · 2021: $109 · 2022: $33.16 · 2023: $188 · 2024: $404 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $637.72 | 2019-2025 | Nucala, Trelegy Ellipta |
| Philips North America LLC | $206.18 | 2019-2020 | |
| Harmony Biosciences LLC | $109.36 | 2020-2023 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.46 | 2020-2025 | Ofev, Jascayd |
| Merck Sharp & Dohme LLC | $87.56 | 2024-2025 | Capvaxive, Winrevair, Gardasil 9 |
| Actelion Pharmaceuticals US, INC. | $79.55 | 2019 | |
| Pulmonx Corporation | $61.99 | 2022-2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Jazz Pharmaceuticals INC. | $43.34 | 2024 | |
| Genentech USA, INC. | $39.35 | 2019-2020 | |
| Inspire Medical Systems, INC. | $37.97 | 2023-2024 | Inspire |
| Sunovion Pharmaceuticals INC. | $37.12 | 2019 | |
| United Therapeutics Corporation | $32.78 | 2025 | Tyvaso |
| Electromed, INC. | $32.42 | 2024 | Smartvest |
| Shionogi INC | $28.93 | 2023 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $28.52 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $26.19 | 2024 | |
| Exact Sciences Corporation | $24.15 | 2025 | Cologuard Collection Kit |
| Genzyme Corporation | $22.62 | 2020 | |
| Allergan, INC. | $22.61 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.72 | 2025 | |
| Insmed, INC. | $16.24 | 2021 | |
| Pfizer INC. | $15.35 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Hakimisefat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.